Key Takeaways
Houlihan Lokey's fiscal Q4 2026 results, released on May 6, 2026, presented a mixed picture, falling short of Wall Street's consensus estimates for both the top and bottom lines. The investment bank reported adjusted earnings per share (EPS) of $1.63, missing the analyst consensus of $1.79 by -$0.16. This represents a notable -6.1% decline compared to the $1.96 EPS reported in the year-ago Q4 2025.
Revenue for the quarter also disappointed, coming in at $635.64 million against an expected $687.1 million. This -7.49% revenue surprise marked a -4.60% year-over-year decline from the $666 million generated in Q4 2025. The results underscore the "difficult quarter" and "challenging backdrop" that analysts had braced for, with geopolitical uncertainty and sector-specific volatility impacting deal timelines.
Despite the quarterly miss, it's crucial to view these figures within the context of the broader fiscal year. Houlihan Lokey achieved record annual revenue of $2.62 billion for FY2026, an increase from $2.39 billion in the prior year, alongside an adjusted EPS of $7.56, up 20% year-over-year. This dichotomy highlights that while the final quarter faced headwinds, the firm demonstrated strong performance throughout the fiscal year, building on its diversified business model.
The market's reaction to the Q4 miss was evident, with HLI shares trading at $147.23, down -1.96% on the day of the announcement. This dip reflects investor sensitivity to short-term performance, especially for a company that has historically shown a strong track record of beating revenue estimates. The wider range of analyst estimates for EPS, from $1.64 to $2.01, prior to the release, suggested a degree of uncertainty regarding the firm's ability to navigate the prevailing market conditions.
Houlihan Lokey's segment-level performance in Q4 FY2026 revealed varying degrees of resilience and vulnerability to the prevailing market conditions. The Corporate Finance segment, a cornerstone of HLI's business, reported revenues of $433.77 million. While this was a robust figure, it still fell short of the three-analyst average estimate of $448.84 million. The segment's strength was partially offset by a decrease in average transaction fees on closed deals, a trend also observed in Financial Restructuring.
The Financial Restructuring segment, traditionally a counter-cyclical strength for HLI, faced unexpected challenges. Revenues came in at $110.38 million, significantly below the $137.21 million average estimate. Management commentary indicated that geopolitical uncertainty and volatility in the software sector led to extended M&A timelines, pushing the closing of two larger restructuring deals beyond the quarter's end. This delay impacted the segment's quarterly performance and may moderate early FY2027 growth.
The Financial and Valuation Advisory (FVA) segment also underperformed, with revenues of $91.49 million against an estimated $95.51 million. Despite this, both Corporate Finance and FVA achieved their highest Q4 revenues ever, demonstrating underlying strength and market positioning. The firm's ability to attract senior talent remained strong, with 33 new Managing Directors hired or acquired in FY2026 and 25 more promoted in Q1 FY2027, expanding its global footprint to 33 locations and 2,776 employees.
These segment results highlight the nuanced impact of the current economic environment. While the firm's diversified model provides a buffer, even its traditionally robust segments are not immune to market-wide delays and reduced transaction fees. The strong hiring and expansion, however, signal management's long-term confidence and strategic investment through the cycle, aiming to capitalize on future market upturns and maintain its competitive edge as a leading global investment bank.
Despite the Q4 FY2026 miss, Houlihan Lokey's full fiscal year 2026 performance paints a picture of underlying strength and strategic positioning. The company achieved record annual revenue of $2.62 billion, up 10% year-over-year, and adjusted EPS of $7.56, a 20% increase from the previous fiscal year. This robust full-year growth, coupled with a five-year revenue CAGR of 11%, underscores the firm's consistent ability to expand its business.
Analyst sentiment remains largely positive, with a consensus "Buy" rating from 15 analysts (9 Buy, 5 Hold, 1 Sell). The average analyst price target stands at $200.00, with a median of $196.00, suggesting significant upside from the current price of $147.23. This optimism is supported by HLI's strong adjusted pre-tax margins, which stood at 23.0% for FY2026, indicating efficient operations and profitability.
The firm's strategic investments in talent acquisition and geographic expansion are also key drivers of this positive outlook. The addition of 33 Managing Directors in FY2026 and the promotion of 25 more in Q1 FY2027 demonstrate a commitment to strengthening its global platform and expertise. This expansion is crucial for capturing market share in diverse advisory verticals and leveraging its "No. 1" rankings in global M&A transactions, U.S. M&A, global restructuring, and M&A fairness opinions.
Looking ahead, the firm's record backlog and pipeline, as well as the increased number of managing directors, are expected to support long-term growth. While near-term volatility and timing delays impacted Q4, the strengthening outlook for Financial Restructuring, driven by a more active distressed market, could provide a significant tailwind. The market will be closely watching management's commentary on fiscal 2027 revenue trends and market share dynamics to gauge the pace of this anticipated recovery.
Assessing Houlihan Lokey's valuation requires a look beyond the recent quarterly miss and into its fundamental financial health and market positioning. Currently, HLI trades at a P/E ratio of 21.91, which is reasonable for a high-performing investment bank with strong growth prospects. Its P/S ratio of 3.88 and P/FCF of 13.90 also suggest a company that generates solid revenue and free cash flow relative to its market capitalization of $10.27 billion.
The firm's balance sheet remains robust, with approximately $1.1 billion in unrestricted cash and investment securities. A current ratio of 1.60 indicates healthy liquidity, while a net debt/EBITDA of -0.84 highlights a net cash position, providing significant financial flexibility for strategic initiatives, acquisitions, or shareholder returns. The dividend yield of 1.6%, with a payout ratio of 38.7%, demonstrates a commitment to returning capital to shareholders while retaining ample funds for reinvestment.
From a growth perspective, HLI's TTM figures are impressive: revenue growth of 24.8%, net income growth of 42.6%, and EPS growth of 41.6%. These figures, while reflecting a strong period, also set a high bar for future performance. The 3-year cumulative revenue growth per share of 4.1% and 5-year cumulative revenue growth per share of 94.9% showcase a company that has consistently expanded its top line over the longer term.
Considering the analyst consensus price target of $200.00, the stock appears undervalued at its current price of $147.23. The 35.8% potential upside suggests that analysts believe the Q4 miss is a temporary setback rather than a fundamental shift in the company's trajectory. Its strong returns on equity (20.1%), assets (11.4%), and invested capital (14.2%) further bolster the argument for its intrinsic value, indicating efficient capital deployment and profitability.
Investing in Houlihan Lokey, like any financial advisory firm, comes with inherent risks tied to the cyclical nature of the global economy and capital markets. The primary risk is a prolonged downturn in M&A activity or a sustained period of low interest rates, which can depress transaction volumes and fee generation in its Corporate Finance and Financial and Valuation Advisory segments. The Q4 FY2026 results, with delays in deal closings due to geopolitical uncertainty and software sector volatility, serve as a recent reminder of these sensitivities.
Another risk lies in the highly competitive landscape of investment banking. While HLI boasts strong market share in several key areas, maintaining this leadership requires continuous investment in talent, technology, and strategic acquisitions. A failure to attract and retain top managing directors, or intense fee compression from larger bulge-bracket banks, could impact profitability. The average transaction fees on closed deals decreasing in both Corporate Finance and Financial Restructuring segments in Q2 FY2026 highlights this pressure.
However, HLI also presents compelling opportunities. Its Financial Restructuring segment acts as a natural hedge during economic downturns, as increased corporate distress drives demand for its advisory services. The strengthening outlook for this segment, with an anticipated increase in distressed situations, could provide a significant revenue stream in the coming fiscal years. This counter-cyclical strength differentiates HLI from many of its peers.
Furthermore, HLI's global expansion and diversified service offerings across industries and geographies reduce its reliance on any single market or sector. The firm's consistent ability to grow its managing director headcount and expand its office footprint positions it to capture market share in an evolving advisory landscape. Its strong balance sheet and cash position also provide the flexibility to pursue strategic acquisitions, further enhancing its capabilities and market reach.
Houlihan Lokey's Q4 FY2026 results, while a slight stumble, should be viewed as a temporary blip in an otherwise strong fiscal year. The firm's record annual revenue and adjusted EPS, coupled with its strategic investments in talent and global reach, underscore a robust long-term growth trajectory. Investors should closely monitor the pace of M&A recovery and the anticipated uptick in restructuring activity, as these will be key determinants of HLI's performance in the coming quarters. The firm's diversified model and strong financial health position it well to navigate market uncertainties and capitalize on future opportunities.
Want deeper research on any stock? Try Kavout Pro for AI-powered analysis, smart signals, and more. Already a member? Add credits to run more research.
